First Light Asset Management as of Dec. 31, 2015
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 65 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NeoGenomics (NEO) | 10.2 | $24M | 3.1M | 7.87 | |
| AtriCure (ATRC) | 8.7 | $21M | 923k | 22.44 | |
| Akorn | 5.3 | $13M | 342k | 37.31 | |
| Enzo Biochem (ENZ) | 4.3 | $10M | 2.3M | 4.50 | |
| Teligent | 3.7 | $8.9M | 999k | 8.90 | |
| LHC | 3.1 | $7.3M | 162k | 45.29 | |
| Harvard Bioscience (HBIO) | 3.0 | $7.1M | 2.0M | 3.47 | |
| Endologix | 2.9 | $7.0M | 703k | 9.90 | |
| LeMaitre Vascular (LMAT) | 2.8 | $6.6M | 382k | 17.25 | |
| Entellus Medical Cm | 2.8 | $6.6M | 392k | 16.86 | |
| Ligand Pharmaceuticals In (LGND) | 2.6 | $6.2M | 57k | 108.42 | |
| Amedisys (AMED) | 2.4 | $5.8M | 146k | 39.32 | |
| Oxford Immunotec Global | 2.4 | $5.8M | 501k | 11.50 | |
| NxStage Medical | 2.3 | $5.5M | 251k | 21.91 | |
| Physicians Realty Trust | 2.2 | $5.4M | 318k | 16.86 | |
| Tearlab Corp | 2.2 | $5.2M | 3.8M | 1.39 | |
| Alkermes (ALKS) | 2.1 | $5.0M | 64k | 79.37 | |
| Insmed (INSM) | 1.9 | $4.6M | 253k | 18.15 | |
| Cynapsus Therapeutics | 1.9 | $4.5M | 296k | 15.29 | |
| Ldr Hldg | 1.9 | $4.4M | 177k | 25.11 | |
| Bluebird Bio (BLUE) | 1.8 | $4.2M | 66k | 64.22 | |
| Quidel Corporation | 1.7 | $4.1M | 195k | 21.20 | |
| Medivation | 1.7 | $4.1M | 84k | 48.34 | |
| Spectranetics Corporation | 1.7 | $4.0M | 266k | 15.06 | |
| RTI Biologics | 1.7 | $4.0M | 1.0M | 3.97 | |
| Veracyte (VCYT) | 1.6 | $3.8M | 533k | 7.20 | |
| Medicines Company | 1.5 | $3.5M | 94k | 37.34 | |
| Envision Healthcare Hlds | 1.4 | $3.5M | 133k | 25.97 | |
| Celldex Therapeutics | 1.4 | $3.3M | 208k | 15.68 | |
| AngioDynamics (ANGO) | 1.3 | $3.2M | 262k | 12.14 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $3.1M | 24k | 125.82 | |
| Arrowhead Research | 1.2 | $2.8M | 463k | 6.15 | |
| Immunomedics | 1.1 | $2.6M | 851k | 3.07 | |
| HealthStream (HSTM) | 1.1 | $2.6M | 117k | 22.00 | |
| Streamline Health Solutions (STRM) | 1.0 | $2.5M | 1.7M | 1.41 | |
| Array BioPharma | 0.9 | $2.2M | 530k | 4.22 | |
| Bio-techne Corporation (TECH) | 0.9 | $2.2M | 25k | 90.00 | |
| Aratana Therapeutics | 0.9 | $2.2M | 395k | 5.58 | |
| Cepheid | 0.9 | $2.2M | 60k | 36.54 | |
| Karyopharm Therapeutics (KPTI) | 0.8 | $2.0M | 153k | 13.25 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $2.0M | 19k | 104.76 | |
| Allergan | 0.3 | $636k | 2.0k | 312.53 | |
| Humana (HUM) | 0.3 | $632k | 3.5k | 178.53 | |
| United Therapeutics Corporation (UTHR) | 0.2 | $598k | 3.8k | 156.54 | |
| Bristol Myers Squibb (BMY) | 0.2 | $570k | 8.3k | 68.76 | |
| Aetna | 0.2 | $564k | 5.2k | 108.15 | |
| Anthem (ELV) | 0.2 | $571k | 4.1k | 139.44 | |
| Becton, Dickinson and (BDX) | 0.2 | $523k | 3.4k | 154.05 | |
| Novartis (NVS) | 0.2 | $522k | 6.1k | 86.00 | |
| Mylan Nv | 0.2 | $529k | 9.8k | 54.12 | |
| BioScrip | 0.2 | $493k | 282k | 1.75 | |
| Celgene Corporation | 0.2 | $513k | 4.3k | 119.86 | |
| Endo International (ENDPQ) | 0.2 | $500k | 8.2k | 61.27 | |
| Steris Corporation | 0.2 | $477k | 6.3k | 75.36 | |
| Eli Lilly & Co. (LLY) | 0.2 | $463k | 5.5k | 84.26 | |
| Johnson & Johnson (JNJ) | 0.2 | $392k | 3.8k | 102.62 | |
| AstraZeneca (AZN) | 0.2 | $386k | 11k | 33.98 | |
| Amgen (AMGN) | 0.2 | $378k | 2.3k | 162.23 | |
| St. Jude Medical | 0.2 | $374k | 6.1k | 61.77 | |
| Merck & Co (MRK) | 0.1 | $349k | 6.6k | 52.80 | |
| Pfizer (PFE) | 0.1 | $340k | 11k | 32.32 | |
| Myriad Genetics (MYGN) | 0.1 | $338k | 7.8k | 43.22 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $242k | 5.7k | 42.61 | |
| Bio-Rad Laboratories (BIO) | 0.1 | $232k | 1.7k | 138.51 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $214k | 5.1k | 41.80 |
